HDL Is Not Dead Yet
High-density lipoprotein cholesterol (HDL-C) levels are inversely correlated with coronary heart disease (CHD) in multiple epidemiological studies, but whether HDL is causal or merely associated with CHD is unclear. Recent trials for HDL-raising drugs were either not effective in reducing CHD events...
Main Authors: | Shuhui Wang Lorkowski, Jonathan D. Smith |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/10/1/128 |
Similar Items
-
Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes
by: Shuhui Wang Lorkowski, et al.
Published: (2020-04-01) -
Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition
by: Shifa Jebari-Benslaiman, et al.
Published: (2020-09-01) -
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
by: Marco Zuin, et al.
Published: (2021-05-01) -
by: William M. Brown, et al.
Published: (2008-04-01) -
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential Therapeutic
by: Emily E. Morin, et al.
Published: (2018-11-01)